Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription 08.09.2025 1 Am J Surg 1 Ann Oncol 10 Ann Surg Oncol 1 BMC Cancer 4 Br J Cancer 3 Breast Cancer 2 Breast Cancer (Dove Med Press) 3 Breast Cancer Res 5 Breast Cancer Res Treat 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 1 Cancer Res 2 Carcinogenesis 1 Cell 7 Clin Breast Cancer 2 Clin Cancer Res 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 3 J Biol Chem 1 J Clin Oncol 3 J Natl Cancer Inst 1 J Nucl Med 1 J Pathol 1 NPJ Breast Cancer 1 Oncogene 1 Oncol Rep 6 PLoS One 2 Proc Natl Acad Sci U S A 1 Radiol Artif Intell 1 Radiol Imaging Cancer 3 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. THOMPSON DM, Kuchta K, Simovic S, Yao KA, et al
   Breast cancer trends and outcomes among young Black Women: A national cancer database analysis.
   Am J Surg. 2025 Aug 13:116577. doi: 10.1016/j.amjsurg.2025.116577.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. CONTE PF, Dieci MV, Bisagni G, Schmid P, et al
   A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients.
   Ann Oncol. 2025 Aug 28:S0923-7534(25)00925-1. doi: 10.1016/j.annonc.2025.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. LIN Y, Wang YY, Xu ZB, Dong L, et al
   ASO Visual Abstract: miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis.
   Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18205.
   PubMed        
   
   
4. MARIN C, Strawderman M, Peterson D, Cheng Z, et al
   ASO Visual Abstract: Biology is Queen-The Oncotype DX 21-Gene Recurrence Score has Stronger Prognostic Ability than Lymph Node Burden for Patients with Breast Cancer.
   Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18244.
   PubMed        
   
   
5. OROZCO JIJ, Valdez BJ, Trasatti ES, Brown SM, et al
   Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?
   Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18284.
   PubMed        
   
   
6. AN SJ, Thai CHNC, Agala CB, Abdou YG, et al
   ASO Visual Abstract: Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
   Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18238.
   PubMed        
   
   
7. FUJINO S, Yamashita K, Okamoto R, Shibaki S, et al
   ASO Visual Abstract: Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.
   Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18105.
   PubMed        
   
   
8. DE JESUS EM, Elmore LC, Fayanju OM
   Annals of Surgical Oncology Landmark Series Disparities in Surgical Oncology: Breast Cancer.
   Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18157.
   PubMed         Abstract available
   
   
9. THOMPSON D, Fefferman M, Simovic S, Kuchta K, et al
   ASO Visual Abstract: Impact of Quality Improvement Interventions on Biopsy to Treatment Time in Breast Cancer-Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.
   Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18179.
   PubMed        
   
   
10. CHAKRABORTY MA, Haffty BG
    ASO Author Reflections: Preoperative Radiation Boost Reduces Re-Excision Rate and Locoregional Treatment Time in Early-Stage Breast Cancer Patients.
    Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18271.
    PubMed        
    
    
11. YUEN S, McCool K, Bharucha M, Narloch K, et al
    ASO Visual Abstract: Evaluating Trends in Fertility Counseling Among Reproductive-Age Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18129.
    PubMed        
    
    
12. CHAKRABORTY MA, Sherwani ZK, Narra LR, Abou Yehia Z, et al
    ASO Visual Abstract: Preoperative Radiation Boosts Results in Low Rates of Re-Excision and Reduced Locoregional Treatment Time for Breast Cancer Patients.
    Ann Surg Oncol. 2025 Sep 1. doi: 10.1245/s10434-025-18245.
    PubMed        
    
    

    
    BMC Cancer

13. YANG Y, Zhao Y, Yao K, Li W, et al
    The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients.
    BMC Cancer. 2025;25:1403.
    PubMed         Abstract available
    
    

    
    Br J Cancer

14. FLAHERTY RL, Falcinelli M, Hesketh AR, Patel BA, et al
    Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriers.
    Br J Cancer. 2025 Jul 2. doi: 10.1038/s41416-025-03085.
    PubMed         Abstract available
    
    
15. DUSTIN D, Gu G, Beyer AR, Herzog SK, et al
    Correction: RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
    Br J Cancer. 2025 Sep 1. doi: 10.1038/s41416-025-03096.
    PubMed        
    
    
16. WANG T, Zeleznik OA, McGee EE, Brantley KD, et al
    Prospective study of circulating metabolomic profiles and breast cancer incidence among predominantly premenopausal women.
    Br J Cancer. 2025 Sep 4. doi: 10.1038/s41416-025-03159.
    PubMed         Abstract available
    
    
17. WOYTASH JA, Lefebvre AEYT, Zhang Z, Xu B, et al
    CDCP1/mitochondrial Src axis increases electron transport chain function to promote metastasis in triple-negative breast cancer.
    Br J Cancer. 2025 Sep 4. doi: 10.1038/s41416-025-03163.
    PubMed         Abstract available
    
    

    
    Breast Cancer

18. SHIN S, Chang Y, Ryu S
    Deep learning mammography-based breast cancer risk model, its serial change, and breast cancer mortality.
    Breast Cancer. 2025 Sep 3. doi: 10.1007/s12282-025-01772.
    PubMed         Abstract available
    
    
19. JALILI F, Hajizadeh M, Mehrabani S, Ghoreishy SM, et al
    The association between neighborhood socioeconomic status and breast cancer incidence and mortality risk: a large-scale cohort studies systematic review and meta-analysis.
    Breast Cancer. 2025 Aug 30. doi: 10.1007/s12282-025-01764.
    PubMed         Abstract available
    
    
20. YE F, Chen X, Cao Y, You Z, et al
    The global, regional, and national disease burden of breast cancer attributable to behavioral risks from 1990 to 2021 and projections to 2035: a systematic analysis of the Global Burden of Disease Study 2021.
    Breast Cancer. 2025 Aug 30. doi: 10.1007/s12282-025-01771.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

21. BUYUKASIK S, Kankaya B, Altundal YE, Ozgul M, et al
    Age and Education Influencing Willingness in Men to Recommend Breast Cancer Screening: A Comparative Study of University Personnel and Clinical Attendees.
    Breast Cancer (Dove Med Press). 2025;17:741-754.
    PubMed         Abstract available
    
    
22. AIMAITI X, Wang Y, Ismtula D, Li Y, et al
    Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.
    Breast Cancer (Dove Med Press). 2025;17:755-779.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

23. LI Y, Liu W, Yu Y, Wang Y, et al
    Early thelarche, reproductive hormones, and MRI-based breast density: a prospective study in China.
    Breast Cancer Res. 2025;27:158.
    PubMed         Abstract available
    
    
24. WU HC, Liao Y, Lai Y, Lin PH, et al
    The plasma proteome and breast cancer risk.
    Breast Cancer Res. 2025;27:157.
    PubMed         Abstract available
    
    
25. BOYACI C, Sun W, Hartman J, Acs B, et al
    Global scoring method of Ki67 immunohistochemistry in breast cancer demonstrates improved concordance using real-world multi-institutional data.
    Breast Cancer Res. 2025;27:159.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

26. SIREK A, Sirek T, Nowakowski R, Borawski P, et al
    Correction to: Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2 + subtypes.
    Breast Cancer Res Treat. 2025 Sep 5. doi: 10.1007/s10549-025-07807.
    PubMed        
    
    
27. LEE JJ, Jettinghoff W, Arbour G, Zepeda A, et al
    Natural language processing for local, regional, and distant breast cancer relapse identification in pathology reports.
    Breast Cancer Res Treat. 2025 Sep 2. doi: 10.1007/s10549-025-07801.
    PubMed         Abstract available
    
    
28. LIN HK, Dai J, Pusztai L
    Integrating large-scale in vitro functional genomic screen and multi-omics data to identify novel breast cancer targets.
    Breast Cancer Res Treat. 2025 Sep 1. doi: 10.1007/s10549-025-07817.
    PubMed         Abstract available
    
    
29. SCHRUP S, Maimone S, Villalba M, Vierkant RA, et al
    High-resolution microCT to assess breast microcalcification morphometry by histologic lesion subtype and radiologic classification.
    Breast Cancer Res Treat. 2025;214:49-58.
    PubMed         Abstract available
    
    
30. SHANTHAKUMAR D, Chalau V, Shi Y, Ranjitkar R, et al
    Diffuse reflectance and fluorescence spectroscopy for breast conserving surgery.
    Breast Cancer Res Treat. 2025;214:25-36.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

31. CHOI HL, Jung W, Youn J, Kim B, et al
    Risk of Parkinson's Disease Among Breast Cancer Survivors: A Nationwide Cohort Study in South Korea.
    Cancer Epidemiol Biomarkers Prev. 2025 Sep 4. doi: 10.1158/1055-9965.EPI-25-0712
    PubMed         Abstract available
    
    

    
    Cancer Lett

32. TAN C, Lyu H, Ruan S, Wu Y, et al
    Subtype-specific HER3 enrichment in basal-like breast cancer is regulated via the GATA2/GATA3-FOXA1 axis.
    Cancer Lett. 2025 Sep 2:218001. doi: 10.1016/j.canlet.2025.218001.
    PubMed         Abstract available
    
    

    
    Cancer Res

33. AVELLINO A, Jiang X, Lee M, Yu J, et al
    An Olive Oil-Based High-Fat Diet Promotes Obesity-Driven Metastasis of Triple-Negative Breast Cancer.
    Cancer Res. 2025 Sep 5. doi: 10.1158/0008-5472.CAN-25-0822.
    PubMed         Abstract available
    
    

    
    Carcinogenesis

34. JEYAKUMAR E, Sundararaju S, Annett S, Elrayess MA, et al
    Mammary Adipose Dysfunction in the Dual Epidemic of Obesity and Breast Cancer.
    Carcinogenesis. 2025 Sep 3:bgaf053. doi: 10.1093.
    PubMed         Abstract available
    
    
35. 
    Correction to: p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.
    Carcinogenesis. 2025;46:bgaf042.
    PubMed        
    
    

    
    Cell

36. WANG K, Ye R, Bai S, Xiao Z, et al
    Coalescing single-cell genomes and transcriptomes to decode breast cancer progression.
    Cell. 2025 Aug 26:S0092-8674(25)00926-2. doi: 10.1016/j.cell.2025.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

37. ANDERSON L, Bhattacharyya O, Clark A, Smith S, et al
    Preferences for Breast Cancer Survivorship Programs Among Multiracial and Ethnic Women.
    Clin Breast Cancer. 2025 Jul 24:S1526-8209(25)00216.
    PubMed         Abstract available
    
    
38. LIU GY, Huang DP, Ge C, Li XY, et al
    SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating beta-catenin signaling.
    Clin Breast Cancer. 2025 Aug 7:S1526-8209(25)00227.
    PubMed         Abstract available
    
    
39. MOHSIN MD, Salihi A
    Mechanistic Insights and Therapeutic Implications of Endothelial Nitric Oxide Synthase and Reactive Oxygen Species in Breast Cancer.
    Clin Breast Cancer. 2025 Aug 8:S1526-8209(25)00231.
    PubMed         Abstract available
    
    
40. VILLA P, Cassani C, Nappi RE, Bounous VE, et al
    Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY).
    Clin Breast Cancer. 2025 Aug 7:S1526-8209(25)00228.
    PubMed         Abstract available
    
    
41. XU H, Li H, Fan Y, Zhang S, et al
    Trajectory of Chemotherapy-Induced Peripheral Neuropathy and Its Predictive Factors in Breast Cancer Patients: A Prospective Longitudinal Study.
    Clin Breast Cancer. 2025 Aug 10:S1526-8209(25)00229.
    PubMed         Abstract available
    
    
42. JANSEN BAM, Bargon CA, Young-Afat DA, Doeksen A, et al
    Minimal Clinically Important Differences in Scales Measuring Decision Uncertainty, Distress After a Traumatic Event, Body Image and Health Status Among Women With Breast Cancer Having Surgery.
    Clin Breast Cancer. 2025 Aug 5:S1526-8209(25)00218.
    PubMed         Abstract available
    
    
43. TIBBETTS KQ, Huang K, Goltz D, Levin M, et al
    The Incidence of Premature Bone Demineralization in Breast Cancer Patients Under 65.
    Clin Breast Cancer. 2025 Aug 11:S1526-8209(25)00233.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

44. PETRICOIN EF, Wolf DM, Yau C, Wulfkuhle JD, et al
    Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.
    Clin Cancer Res. 2025 Sep 4:OF1-OF11. doi: 10.1158/1078-0432.CCR-25-0553.
    PubMed         Abstract available
    
    
45. MIGLIETTA F, De Graaf M, Vernieri C, Piacentini F, et al
    Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trial.
    Clin Cancer Res. 2025 Sep 4. doi: 10.1158/1078-0432.CCR-25-1796.
    PubMed         Abstract available
    
    

    
    Int J Cancer

46. VANDRAAS KF, Hjorth S, Trewin-Nybraten CB, Ursin G, et al
    Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment.
    Int J Cancer. 2025 Sep 2. doi: 10.1002/ijc.70120.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

47. LAKOMY DS, Kennedy WR, Laugeman E, Huang Y, et al
    Long-Term Results of a Phase II Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 3:S0360-3016(25)06004.
    PubMed         Abstract available
    
    

    
    J Biol Chem

48. LI X, Chung YM, Patel M, Sharifi N, et al
    Correction: of HSD3B1 upregulation via LRH1 sustains estrogen receptor signaling and promotes endocrine resistance in breast cancer.
    J Biol Chem. 2025;301:110553.
    PubMed        
    
    
49. ZHAO M, Yuan D, Wei M, Zhang J, et al
    FOXO1- mediated argininosuccinate lyase transcription inhibits ammonia metabolism and breast cancer cell metastasis.
    J Biol Chem. 2025 Sep 2:110677. doi: 10.1016/j.jbc.2025.110677.
    PubMed         Abstract available
    
    
50. NANDI S, Mondal A, Sarkar I, Akram Ddoza Hazari MW, et al
    The Hypoxia-Induced Chromatin Reader ZMYND8 Drives HIF-Dependent Metabolic Rewiring in Breast Cancer.
    J Biol Chem. 2025 Sep 3:110680. doi: 10.1016/j.jbc.2025.110680.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

51. PATEL BK, Carnahan MB, Northfelt D, Anderson K, et al
    Erratum: Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round.
    J Clin Oncol. 2025 Sep 2:JCO2501993. doi: 10.1200/JCO-25-01993.
    PubMed        
    
    

    
    J Natl Cancer Inst

52. SAHIN TK, Guven DC, Aksoy S
    RE: Aprepitant use during chemotherapy and association with survival in women with early breast cancer.
    J Natl Cancer Inst. 2025 Sep 3:djaf254. doi: 10.1093.
    PubMed        
    
    
53. PRESTI D, Di Meglio A, Havas J, Pagliuca M, et al
    Risk models of cancer related cognitive complaints among early breast cancer survivors in the CANTO cohort.
    J Natl Cancer Inst. 2025 Sep 3:djaf256. doi: 10.1093.
    PubMed         Abstract available
    
    
54. IRAJIZAD E, Hanash S
    Breast cancer risk assessment: current challenges and the emerging role of blood-based protein biomarkers.
    J Natl Cancer Inst. 2025 Sep 3:djaf215. doi: 10.1093.
    PubMed        
    
    

    
    J Nucl Med

55. HUANG W, Li L, Chao F, Yang Q, et al
    [(64)Cu]Cu-NOTA-EV-F(ab')(2) Enables Same-Day Immuno-PET Imaging of Nectin-4 in Triple-Negative Breast and Urothelial Bladder Cancers.
    J Nucl Med. 2025 Aug 7:jnumed.125.270132. doi: 10.2967/jnumed.125.270132.
    PubMed         Abstract available
    
    

    
    J Pathol

56. LI W, He J, Li J, Xie X, et al
    High-fat diets influence breast cancer progression by modulating CAF-immune cell interactions through PLAT signaling.
    J Pathol. 2025 Sep 3. doi: 10.1002/path.6452.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

57. MISIAKOU MA, Jensen MB, Talman ML, Ejlertsen B, et al
    Enhancing HER2-low breast cancer detection with quantitative transcriptomics.
    NPJ Breast Cancer. 2025;11:98.
    PubMed         Abstract available
    
    

    
    Oncogene

58. UMBRICHT CB, Evron E, Gabrielson E, Ferguson AT, et al
    Correction: Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
    Oncogene. 2025 Sep 5. doi: 10.1038/s41388-025-03555.
    PubMed        
    
    

    
    Oncol Rep

59. LUO X, Wei Y, Lin H, Xiao N, et al
    BUB1B promotes homologous recombination?mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway.
    Oncol Rep. 2025;54:147.
    PubMed         Abstract available
    
    

    
    PLoS One

60. ARIK A, Cairns AJG, Streftaris G
    Cancer disparities: Projection, COVID-19, and scenario-based diagnosis delay impact.
    PLoS One. 2025;20:e0330752.
    PubMed         Abstract available
    
    
61. LIAO Y, Mohd Hairon S, Majdi Yaacob N, Alina Tengku Ismail T, et al
    Psychometric validation of a culturally adapted health belief model scale for breast cancer screening in Chinese women.
    PLoS One. 2025;20:e0331279.
    PubMed         Abstract available
    
    
62. JASSIM GHRABAT MJ, Ghaib AA, Al-Hossenat A, Abduljabbar ZA, et al
    Effective SMOTE boost with deep learning for IDC identification in whole-slide images.
    PLoS One. 2025;20:e0329078.
    PubMed         Abstract available
    
    
63. XIONG J, Zhang D, Yuan Y, Quan C, et al
    Association between Systemic Immune-Inflammation Index and female breast cancer based on NHANES data (2001-2018): A cross-sectional study.
    PLoS One. 2025;20:e0330571.
    PubMed         Abstract available
    
    
64. KONAKA Y, Ueda T, Inamori R, Sato J, et al
    Breast cancer classification based on the integration of diagnostic algorithms for calcifications and masses using a mixture of experts.
    PLoS One. 2025;20:e0331017.
    PubMed         Abstract available
    
    
65. ALOMAIRY NA
    The impact of breast cancer awareness campaigns on the knowledge, attitudes, and practices of breast cancer screening among Saudi female employees.
    PLoS One. 2025;20:e0331765.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

66. DANG CAO TL, Kawanishi K, Hashimoto S, Hengphasatporn K, et al
    Tumor-expressed GPNMB orchestrates Siglec-9(+) TAM polarization and EMT to promote metastasis in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2503081122.
    PubMed         Abstract available
    
    
67. ZHANG J, Zhang J, Han L, Wu S, et al
    Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.
    Proc Natl Acad Sci U S A. 2025;122:e2515009122.
    PubMed         Abstract available
    
    

    
    Radiol Artif Intell

68. WANG YK, Klanecek Z, Wagner T, Cockmartin L, et al
    Using Explainable AI to Characterize Features in the Mirai Mammographic Breast Cancer Risk Prediction Model.
    Radiol Artif Intell. 2025 Sep 3:e240417. doi: 10.1148/ryai.240417.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

69. SIGMUND EE, Cho GY, Basukala D, Sutton OM, et al
    Evaluating Breast Cancer Intravoxel Incoherent Motion MRI Biomarkers across Software Platforms.
    Radiol Imaging Cancer. 2025;7:e240115.
    PubMed         Abstract available
    
    

    
    Radiology

70. FREITAS V
    Node Reporting and Data System in Focus: Advancing Precision in Axillary Staging for Breast Cancer.
    Radiology. 2025;316:e252033.
    PubMed        
    
    
71. KIM HJ, Chae EY, Eom HJ, Choi WJ, et al
    Node Reporting and Data System Evaluation of Axillary Nodes in Invasive Ductal and Lobular Carcinoma.
    Radiology. 2025;316:e243823.
    PubMed         Abstract available
    
    
72. HUANG Y, Song X, Chen Y, Qiu H, et al
    Intratumoral Microbiome-related MRI Model for Predicting Breast Cancer Shrinkage Pattern Following Neoadjuvant Therapy.
    Radiology. 2025;316:e243545.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.